LifePoint Health, Inc. (NASDAQ:LPNT) reported Q2 2017 earnings this Morning, coming in at $0.96 per share, beating Wall Street’s estimates of $0.90 per Share. Revenue for the quarter came in at $1.59 billion missing the streets estimates of $1.64 billion
Analyst Coverage For LifePoint Health, Inc. (NASDAQ:LPNT)
These are 2 Sell Ratings, 9 Hold Ratings, 4 Buy Ratings .
The current consensus rating for LifePoint Health, Inc. (NASDAQ:LPNT) is Hold (Score: 2.13) with a consensus target price of $65.50 , a potential (10.27% upside)Recent Insider Trading for LifePoint Health, Inc. (NASDAQ:LPNT)
- On 7/17/2017 William F Carpenter III, Chairman, sold 17,653 with an average share price of $65.06 per share and the total transaction amounting to $1,148,504.18.
- On 6/15/2017 William F Carpenter III, Chairman, sold 82,347 with an average share price of $64.15 per share and the total transaction amounting to $5,282,560.05.
- On 5/11/2017 Richard H Evans, Director, sold 2,000 with an average share price of $62.88 per share and the total transaction amounting to $125,760.00.
- On 3/30/2017 John P Bumpus, EVP, sold 33,333 with an average share price of $65.00 per share and the total transaction amounting to $2,166,645.00.
- On 3/16/2017 David M Dill, Insider, sold 18,800 with an average share price of $62.22 per share and the total transaction amounting to $1,169,736.00.
- On 3/10/2017 David M Dill, Insider, sold 1,200 with an average share price of $65.00 per share and the total transaction amounting to $78,000.00.
Recent Trading for LifePoint Health, Inc. (NASDAQ:LPNT) Shares of LifePoint Health, Inc. closed the previous trading session at 59.45 up +0.05 0.08% with 496,740 shares trading hands.